DNA Biomed (Israel) Analysis

DNA Stock  ILS 88.80  6.50  6.82%   
DNA Biomed Solns is fairly valued with Real Value of 86.85 and Hype Value of 88.8. The main objective of DNA Biomed stock analysis is to determine its intrinsic value, which is an estimate of what DNA Biomed Solns is worth, separate from its market price. There are two main types of DNA Biomed's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect DNA Biomed's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of DNA Biomed's stock to identify patterns and trends that may indicate its future price movements.
The DNA Biomed stock is traded in Israel on Tel Aviv Stock Exchange, with the market opening at 09:00:00 and closing at 17:30:00 every Mon,Tue,Wed,Thu,Sun except for officially observed holidays in Israel. DNA Stock trading window is adjusted to Asia/Jerusalem timezone. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and DNA Biomed's ongoing operational relationships across important fundamental and technical indicators.
  
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in DNA Biomed Solns. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors.

DNA Stock Analysis Notes

About 55.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 0.95. Some equities with similar Price to Book (P/B) outperform the market in the long run. DNA Biomed Solns had not issued any dividends in recent years. The entity had 1:6 split on the 10th of November 2019. D.N.A Biomedical Solutions Ltd. develops and commercializes laser spectrometry-based trace detection systems in Israel. D.N.A Biomedical Solutions Ltd. was founded in 2004 and is based in Ramat Gan, Israel. D N operates under Biotechnology classification in Israel and is traded on Tel Aviv Stock Exchange. To learn more about DNA Biomed Solns call Yeonatan Malca at 972 3 970 5000 or check out https://www.laser-detect.com.

DNA Biomed Solns Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. DNA Biomed's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding DNA Biomed Solns or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
DNA Biomed Solns appears to be risky and price may revert if volatility continues
The company has a current ratio of 0.03, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist DNA Biomed until it has trouble settling it off, either with new capital or with free cash flow. So, DNA Biomed's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like DNA Biomed Solns sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for DNA to invest in growth at high rates of return. When we think about DNA Biomed's use of debt, we should always consider it together with cash and equity.
DNA Biomed Solns has accumulated about 492 K in cash with (2.33 M) of positive cash flow from operations.
Roughly 55.0% of the company shares are held by company insiders

DNA Market Capitalization

The company currently falls under 'Micro-Cap' category with a current market capitalization of 86.46 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate DNA Biomed's market, we take the total number of its shares issued and multiply it by DNA Biomed's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Technical Drivers

As of the 24th of April, DNA Biomed owns the Downside Deviation of 3.01, market risk adjusted performance of 1.68, and Coefficient Of Variation of 649.78. DNA Biomed Solns technical analysis allows you to utilize past data patterns in order to determine a pattern that computes the direction of the firm's future prices. Strictly speaking, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume patterns, or the prices will eventually revert. We were able to analyze nineteen technical drivers for DNA Biomed, which can be compared to its peers in the sector. Please confirm DNA Biomed Solns jensen alpha, semi variance, and the relationship between the standard deviation and value at risk to decide if DNA Biomed Solns is priced favorably, providing market reflects its prevailing price of 88.8 per share.

DNA Biomed Solns Price Movement Analysis

Execute Study
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. DNA Biomed middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for DNA Biomed Solns. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.

DNA Biomed Predictive Daily Indicators

DNA Biomed intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of DNA Biomed stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

DNA Biomed Forecast Models

DNA Biomed's time-series forecasting models are one of many DNA Biomed's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary DNA Biomed's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About DNA Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how DNA Biomed prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling DNA shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as DNA Biomed. By using and applying DNA Stock analysis, traders can create a robust methodology for identifying DNA entry and exit points for their positions.
D.N.A Biomedical Solutions Ltd. develops and commercializes laser spectrometry-based trace detection systems in Israel. D.N.A Biomedical Solutions Ltd. was founded in 2004 and is based in Ramat Gan, Israel. D N operates under Biotechnology classification in Israel and is traded on Tel Aviv Stock Exchange.

Be your own money manager

As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding DNA Biomed to your portfolios without increasing risk or reducing expected return.

Did you try this?

Run Idea Optimizer Now

   

Idea Optimizer

Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
All  Next Launch Module
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in DNA Biomed Solns. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors.
Note that the DNA Biomed Solns information on this page should be used as a complementary analysis to other DNA Biomed's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.

Complementary Tools for DNA Stock analysis

When running DNA Biomed's price analysis, check to measure DNA Biomed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy DNA Biomed is operating at the current time. Most of DNA Biomed's value examination focuses on studying past and present price action to predict the probability of DNA Biomed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move DNA Biomed's price. Additionally, you may evaluate how the addition of DNA Biomed to your portfolios can decrease your overall portfolio volatility.
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
AI Investment Finder
Use AI to screen and filter profitable investment opportunities
Please note, there is a significant difference between DNA Biomed's value and its price as these two are different measures arrived at by different means. Investors typically determine if DNA Biomed is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, DNA Biomed's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.